Advertisement
Advertisement

ANTX

ANTX logo

AN2 Therapeutics, Inc. Common Stock

4.46
USD
Sponsored
-0.14
-3.04%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

4.46

0.00
0.00%

AN2 Therapeutics, Inc. Common Stock Profile

About

AN2 Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on developing treatments for rare, chronic and serious infectious diseases with high unmet needs. AN2 Therapeutics Inc. is based in MENLO PARK, Calif.

Info & Links

CEO

Eric Easom

Headquarters

1800 EL CAMINO REAL, SUITE 100
MENLO PARK, CA 94025, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.an2therapeutics.com

Auditor

PricewaterhouseCoopers LLP

Share holders

40

Employees

21

AN2 Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

160.54M

Enterprise Value

140.60M

Enterprise Value/EBITDA(ttm)

-3.59

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.58

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-55.04%

Return on Invested Capital(ttm)

-55.82%

Return on Assets(ttm)

-49.13%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-39.18M

Net Income Available to Common(ttm)

-35.17M

Diluted EPS(ttm)

-1.16

Share Statistics

Beta (5Y Monthly)

-1.31

52-Week Change

265.57%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

35.94M

Dividend Yield

0.00%

Float4

27.15M

% Held by Insiders

24.46%

% Held by Institutions

90.47%

Balance Sheet

Total Cash(mrq)

58.00M

Total Cash Per Share(mrq)

1.61

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.87%

Quick Ratio(mrq)

6.87%

Book Value Per Share(mrq)

1.94

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.99

Free Cash Flow(ytd)

-29.83M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement